Evaluate Umbilical Cord-derived Allogeneic Mesenchymal Stem Cells for the Treatment of Bradykinesia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
Investigate the safety and tolerability of umbilical cord-derived allogeneic mesenchymal stem cells to treat patients with Bradykinesia.
Epistemonikos ID: 5e89cf62b6a4a5acd711219fece310ceee6082f2
First added on: May 07, 2024